ABINGDON HEALTH ORD 0.025P overview

Abingdon Health Notes Announcement by UK-RTC on providing an Antibody Certificate using smartphone App technology The Antibody Certificate Solution will provide a tool to support the opening of economies and a return to normal life York, U.K. 19 April 2021: Abingdon Health plc (AIM: ABDX) (“the Company”), a leading international developer and manufacturer of high quality and effective rapid tests, welcomes the announcement today by the UK Rapid Test Consortium (UK-RTC) that the AbC-19™...

AbC-19™ Rapid Test used in UK BioBank COVID-19 Antibody Study The study will investigate the long-term health effects of long COVID York, U.K. 29 March 2021: The UK-RTC is pleased to announce that the AbC-19™ rapid neutralising antibody test is being deployed in Phase 2 of the UK Biobank Coronavirus self-test antibody study. The study will provide researchers with unique opportunities to investigate the long-term health effects of SARS-CoV-2 infection (“long COVID”) and other health...

Webinar: The role of antibody testing as a companion test to SARS-CoV-2 vaccination York, U.K. 10 March 2021: Abingdon Health plc, a leading international developer and manufacturer of high quality and effective rapid tests, will present a webinar entitled ‘ The role of antibody testing as a companion test to SARS-CoV-2 vaccination’ in partnership with Fierce Pharma on Thursday 1st April. The nature of testing for the SARS-CoV-2 virus has changed over the course of the pandemic. Once,...

Abingdon Health Plc signs distribution agreement with BioSure UK 10th March 2021: Abingdon Health, a leading international developer and manufacturer of high quality and effective rapid tests, has signed a non-exclusive sales and distribution agreement in the UK and Europe for the AbC-19 TM rapid neutralising antibody test with BioSure UK, a specialist in the provision of rapid Point of Care tests (POCT) and self-testing solutions. Abingdon Health is a member of the UK-Rapid Test Consortium...

Abingdon Health plc (“the Company”), a leading international developer and manufacturer of high quality and effective rapid tests, announces that the AbC-19™ Rapid Test for the detection of SARS-CoV-2 antibodies is now available for purchase by healthcare professionals on the Abingdon Health website . This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210216005611/en/ The AbC-19™ Rapid Test Process (Graphic: Business Wire) The...

Abingdon Health signs collaboration and co-marketing agreement with Abcam York, and Cambridge U.K. 09 February 2021: Abingdon Health (AIM:ABDX) (“Abingdon” or “the Company”), a leading international developer and manufacturer of high quality and effective rapid tests, has signed a collaboration and co-marketing agreement with Abcam plc (NASDAQ:ABCM; AIM:ABC) (“Abcam”), a global leader in the supply of life science research tools and reagents. The Parties intend to establish a...

Outsourcing vs Inhouse Resourcing For Lateral Flow Test Manufacturing New guide published by leading rapid test developer and manufacturer advises on moving faster, containing risks, and embracing opportunities through outsourced manufacturing York, U.K. 03 February 2021: Abingdon Health (“the Company”), a leading international developer and manufacturer of high quality and effective rapid tests, has today published a new guide highlighting the benefits to businesses of outsourcing lateral...